Paul Hagedoorn

Paul Hagedoorn is a Researcher at the Faculty of Science and Engineering, University of Groningen, specializing in Pharmaceutical Technology and Biopharmacy. His work focuses on inhalation technology, pulmonary drug delivery, and medical device development.

• Expertise in Dry Powder Inhalers and Smart Inhalers
• Active in Cystic Fibrosis, Parkinson's Disease, and Asthma Treatment
• Published extensively on Pharmacokinetics and Digital Health applications

Recent research includes clinical trials on inhaled Tobramycin for cystic fibrosis and Levodopa formulations for Parkinson's disease. He also explores digital monitoring tools for asthma management.

His collaborations span respiratory medicine, neurology, and pharmaceutical engineering, with key contributions to Dry Powder Formulation and Patient-Centered Inhalation Technologies.

Contact: p.hagedoorn@rug.nl